Business
This company has entered a trading halt, is it about to announce FDA approval?
Image source: Getty Images
Orthocell Ltd (ASX: OCC) is an Australian medical technology company focused on developing and commercialising innovative regenerative medicine treatments.
Over the last 12 months its share price has skyrocketed, up more than 260% in that span.
For context, S&P/ASX…
Continue Reading
-
General19 hours agoAustralian economy still vulnerable to US bond turmoil
-
Business15 hours agoWhat I’d buy before the ASX rebounds: 3 high-conviction share picks
-
Noosa News7 hours agoBrisbane Man crushed and seriously injured by metal beam in workplace accident at Logan
-
Business9 hours agoDown 20% this year, here are 3 reasons why I’m still loading up on Amazon stock